Get access

Huntington's disease–like 2 is associated with CUG repeat-containing RNA foci

Authors

  • Dobrila D. Rudnicki PhD,

    1. Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD
    Search for more papers by this author
  • Susan E. Holmes PhD,

    1. Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD
    Search for more papers by this author
  • Mark W. Lin BSc,

    1. Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD
    Search for more papers by this author
  • Charles A. Thornton MD,

    1. Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY
    Search for more papers by this author
  • Christopher A. Ross MD, PhD,

    1. Division of Neurobiology, Department of Psychiatry, Program of Cellular and Molecular Medicine, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD
    2. Department of Neuroscience; Johns Hopkins University School of Medicine, Baltimore, MD
    Search for more papers by this author
  • Russell L. Margolis MD

    Corresponding author
    1. Division of Neurobiology, Department of Psychiatry, Program of Cellular and Molecular Medicine, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD
    2. Department of Neuroscience; Johns Hopkins University School of Medicine, Baltimore, MD
    • CMSC 8-121, 600 North Wolfe Street, Baltimore, MD 21287
    Search for more papers by this author

Abstract

Objective

Huntington's disease–like 2 (HDL2) is caused by a CAG/CTG expansion mutation on chromosome 16q24.3. The repeat falls, in the CTG orientation, within a variably spliced exon of junctophilin-3 (JPH3). The existence of a JPH3 splice variant with the CTG repeat in 3′ untranslated region suggested that transcripts containing an expanded CUG repeat could play a role in the pathogenesis of HDL2, similar to the proposed pathogenic role of expanded CUG repeats in myotonic dystrophy type 1 (DM1). The goal of this study, therefore, was to test the plausibility of an RNA gain-of-function component in the pathogenesis of HDL2.

Methods

The presence and composition of RNA foci in frontal cortex from HDL2, Huntington's disease, DM1, and control brains were investigated by in situ hybridization and immunohistochemistry. An untranslatable JPH3 transcript containing either a normal or an expanded CUG repeat was engineered and expressed in human embryonic kidney 293 and HT22 cells to further test the toxic RNA hypothesis. The formation of RNA foci and the extent of cell death were quantified.

Results

RNA foci resembling DM1 foci were detected in neurons in HDL2 cortex and other brain regions. Similar to DM1, the foci colocalize with muscleblind-like protein 1, and nuclear muscleblind-like protein 1 in HDL2 cortical neurons is decreased relative to controls. In cell experiments, expression of a JPH3 transcript with an expanded CUG repeat resulted in the formation of RNA foci that colocalized with muscleblind-like protein 1 and in cell toxicity.

Interpretation

These results imply that RNA toxicity may contribute to the pathogenesis of HDL2. Ann Neurol 2007;61:272–282

Ancillary